Treatment for patients with Hodgkin’s lymphoma is one of the success stories of modern medicine. A once uniformly fatal disorder is now curable, even in an advanced stage, in the great majority of patients. In fact, particularly in limited-stage Hodgkin’s lymphoma, much of the therapeutic focus is on maintaining the high probability of cure while reducing the incidence of toxic effects. How little therapy can we give without losing efficacy? For patients with advanced-stage, high-risk disease, debates regarding the best currently available approach have centered on the “old standard” ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) regimen,1 the very intensive escalated . . .
"stage" - Google News
July 14, 2022 at 04:01AM
https://ift.tt/lpbjCBR
A Better Treatment for Advanced-Stage Hodgkin's Lymphoma? | NEJM - nejm.org
"stage" - Google News
https://ift.tt/ZfxgcGp
https://ift.tt/BHjz09U
Bagikan Berita Ini
0 Response to "A Better Treatment for Advanced-Stage Hodgkin's Lymphoma? | NEJM - nejm.org"
Post a Comment